Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Additional drugs from other companies that have signed an MFN will be made available through the website in the coming months
Dual-pathway designs enable analysis of synergy and pathway cross-talk in controlled systems
Both companies have faced FDA scrutiny
Differential abundance testing used was unpaired 2-tailed t test
Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice
Liposomal, consistently
US$ 24.37
US$ 29.05
US$ 28.68
US$ 27.38
US$ 23.42
US$ 27.55
